■原 著
Safety and tolerability of nintedanib in patients with systemic sclerosis–associated
interstitial lung disease in clinical practice:
interim analysis of post–marketing surveillance in Japan
Evaluation of safety and clinical outcomes of FF/UMEC/VI therapy in patients with asthma in Japan:
interim analysis of general drug use investigation